{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:05:02Z","timestamp":1769198702495,"version":"3.49.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01311","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T19:22:23Z","timestamp":1593199343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["\u201cSmall\u201d Intestinal Immunopathology Plays a \u201cBig\u201d Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-\u03b3, IL-17A, and a Janus Kinase Inhibitor"],"prefix":"10.3389","volume":"11","author":[{"given":"Shiv D.","family":"Kale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney N.","family":"Mehrkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly M.","family":"Stegman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Kastelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Carnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel J.","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikumar V.","family":"Karyala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl","family":"Coutermarsh-Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie A.","family":"Fretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Koff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govindarajan","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"Cancer J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/CJI.0000000000000236","article-title":"Cytokine release syndrome during sequential treatment with immune checkpoint inhibitors and kinase inhibitors for metastatic melanoma","volume":"42","author":"Dimitriou","year":"2019","journal-title":"J Immunother"},{"key":"B6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40425-019-0582-4","article-title":"Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report","volume":"7","author":"Honjo","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.12688\/f1000research.9092.1","article-title":"Agents to reduce cytokine storm","volume":"5","author":"Gerlach","year":"2016","journal-title":"F1000Research"},{"key":"B10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000100894","article-title":"T cell signalling induced by bacterial superantigens","volume":"93","author":"Bueno","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"B11","first-page":"1","article-title":"Animal models used to study superantigen-mediated diseases","volume-title":"Superantigens: Methods and Protocols.","author":"Brosnahan","year":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1500","DOI":"10.14800\/rci.1500","article-title":"Bacterial superantigen toxins induce a lethal cytokine storm by enhancing B7-2\/CD28 costimulatory receptor engagement, a critical immune checkpoint","volume":"4","author":"Kaempfer","year":"2017","journal-title":"Recept Clin Investig."},{"key":"B13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nm.1965","article-title":"Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome","volume":"15","author":"Chau","year":"2009","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e16764","DOI":"10.1371\/journal.pone.0016764","article-title":"Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome","volume":"6","author":"Tilahun","year":"2011","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1016\/j.ajpath.2011.02.033","article-title":"Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome","volume":"178","author":"Tilahun","year":"2011","journal-title":"Am J Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.4049\/jimmunol.1400980","article-title":"Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome","volume":"193","author":"Tilahun","year":"2014","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1399-0039.2010.01617.x","article-title":"HLA-DR polymorphism modulates response to house dust mites in a transgenic mouse model of airway inflammation","volume":"77","author":"Rajagopalan","year":"2011","journal-title":"Tissue Antigens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e27203","DOI":"10.1371\/journal.pone.0027203","article-title":"Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB","volume":"6","author":"Tilahun","year":"2011","journal-title":"PLoS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1080\/21505594.2016.1267894","article-title":"Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus","volume":"8","author":"Karau","year":"2017","journal-title":"Virulence"},{"key":"B20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.12688\/f1000research.4431.2","article-title":"ReactomeFIViz: a cytoscape app for pathway and network-based data analysis","volume":"3","author":"Wu","year":"2014","journal-title":"F1000Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-\u03b3: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1074\/jbc.R116.774745","article-title":"Current prospects of type II interferon \u03b3 signaling and autoimmunity","volume":"292","author":"Green","year":"2017","journal-title":"J Biol Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9564814","DOI":"10.1155\/2016\/9564814","article-title":"Noncanonical IFN signaling: mechanistic linkage of genetic and epigenetic events","volume":"2016","author":"Johnson","year":"2016","journal-title":"Mediat Inflamm"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK-STAT signaling: lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1128\/AAC.01533-15","article-title":"Treatment of experimental Candida sepsis with a janus kinase inhibitor controls inflammation and prolongs survival","volume":"59","author":"Tsirigotis","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.12688\/f1000research.13167.1","article-title":"JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders","volume":"7","author":"Vainchenker","year":"2018","journal-title":"F1000Research"},{"key":"B33","doi-asserted-by":"publisher","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","article-title":"JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1182\/blood.V122.21.2281.2281","article-title":"CD4+ T cell functions are potently suppressed by the janus kinase 1\/2 (JAK1\/JAK2) inhibitor ruxolitinib","volume":"122","author":"Cornez","year":"2013","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1182\/blood.V122.21.2001.2001","article-title":"The pan-JAK inhibitor ruxolitinib impairs T-cell activation, cytokine production and proliferation in vivo and in vitro","volume":"122","author":"Wolschke","year":"2013","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/bjh.13373","article-title":"JAK1\/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms","volume":"169","author":"Parampalli Yajnanarayana","year":"2015","journal-title":"Br J Haematol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1084\/jem.20110308","article-title":"T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse","volume":"208","author":"Moran","year":"2011","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E3679","DOI":"10.1073\/pnas.1413726111","article-title":"A sharp T-cell antigen receptor signaling threshold for T-cell proliferation","volume":"111","author":"Au-Yeung","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/eci.09.31","article-title":"Monoclonal antibody-induced cytokine-release syndrome","volume":"5","author":"Bugelski","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.1995.03520260077036","article-title":"Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues","volume":"78","author":"Fry","year":"2012","journal-title":"Am Surg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1615\/CritRevImmunol.2015015461","article-title":"Pathogenesis of multiple organ failure in sepsis","volume":"35","author":"Rossaint","year":"2015","journal-title":"Crit Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/clim.2000.4960","article-title":"Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment","volume":"98","author":"Anderson","year":"2001","journal-title":"Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1179\/096805104225004879","article-title":"D-galactosamine lethality model: scope and limitations","volume":"10","author":"Silverstein","year":"2004","journal-title":"J Endotoxin Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1164\/ajrccm.158.2.9710092","article-title":"Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients","volume":"158","author":"Doig","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"B47","first-page":"309","article-title":"Gut failure in critical care: old school versus new school","volume":"28","author":"Sertaridou","year":"2015","journal-title":"Ann Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccc.2015.11.004","article-title":"The gut as the motor of multiple organ dysfunction in critical illness","volume":"32","author":"Klingensmith","year":"2016","journal-title":"Crit Care Clin"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1172\/JCI97912","article-title":"Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure","volume":"128","author":"Armacki","year":"2018","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/shk.0b013e31805569df","article-title":"Intestinal crosstalk: a new paradigm for understanding the gut as the \u201cmotor\u201d of critical illness","volume":"28","author":"Clark","year":"2007","journal-title":"Shock"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1097\/CCM.0b013e31828c26b5","article-title":"Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality","volume":"41","author":"Piton","year":"2013","journal-title":"Crit Care Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jcrc.2016.05.001","article-title":"Association between acute gastrointestinal injury grading system and disease severity and prognosis in critically ill patients: a multicenter, prospective, observational study in China","volume":"36","author":"Li","year":"2016","journal-title":"J Crit Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jcrc.2019.04.001","article-title":"Gastrointestinal failure affects outcome of intensive care","volume":"52","author":"Padar","year":"2019","journal-title":"J Crit Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/SHK.0b013e31817048f7","article-title":"Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock","volume":"30","author":"Rajagopalan","year":"2008","journal-title":"Shock"},{"key":"B55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1152\/physiolgenomics.90385.2008","article-title":"Early gene expression changes induced by the bacterial superantigen, staphylococcal enterotoxin B and its modulation by a proteasome inhibitor","volume":"37","author":"Rajagopalan","year":"2009","journal-title":"Physiol Genomics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2016.02.048","article-title":"Hallmarks of tissue-resident lymphocytes","volume":"164","author":"Fan","year":"2016","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1096\/fj.04-3260com","article-title":"Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process","volume":"19","author":"Bruewer","year":"2005","journal-title":"FASEB J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.immuni.2010.03.001","article-title":"interferon-[gamma] regulates intestinal epithelial homeostasis through converging [beta]-catenin signaling pathways","volume":"32","author":"Nava","year":"2010","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e121886","DOI":"10.1172\/jci.insight.121886","article-title":"Essential role of IFN-\u03b3 in T cell\u2013associated intestinal inflammation","volume":"3","author":"Eriguchi","year":"2018","journal-title":"JCI Insight"},{"key":"B60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/jir.2008.0057","article-title":"Interferon-gamma regulation of intestinal epithelial permeability","volume":"29","author":"Beaurepaire","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/sj.onc.1205255","article-title":"IFN\u03b3 sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway","volume":"21","author":"Fulda","year":"2002","journal-title":"Oncogene"},{"key":"B62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.0959-9673.2003.00363.x","article-title":"STAT-1: a novel regulator of apoptosis","volume":"84","author":"Stephanou","year":"2003","journal-title":"Int J Exp Pathol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2249.2010.04250.x","article-title":"Interfering with interferon-\u03b3 signalling in intestinal epithelial cells: selective inhibition of apoptosis-maintained secretion of anti-inflammatory interleukin-18 binding protein","volume":"163","author":"Schuhmann","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.4049\/jimmunol.1601366","article-title":"Rapid and rigorous IL-17A production by a distinct subpopulation of effector memory T lymphocytes constitutes a novel mechanism of toxic shock syndrome immunopathology","volume":"198","author":"Szabo","year":"2017","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","article-title":"Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice","volume":"110","author":"Ogawa","year":"2004","journal-title":"Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.1736","article-title":"A protective function for interleukin 17A in T cell-mediated intestinal inflammation","volume":"10","author":"O'Connor","year":"2009","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1073\/pnas.0912675107","article-title":"Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis","volume":"107","author":"Chae","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6313","DOI":"10.4049\/jimmunol.1001454","article-title":"Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production","volume":"186","author":"Feng","year":"2011","journal-title":"J Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/mi.2017.97","article-title":"Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation","volume":"11","author":"Li","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"B73","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12876-019-1067-0","article-title":"Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (ixekizumab) for the treatment of chronic plaque psoriasis: a case report","volume":"19","author":"Smith","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10620-020-06161-1","article-title":"Controversial contribution of Th17\/IL-17 toward the immune response in intestinal fibrosis","volume":"65","author":"Latella","year":"2020","journal-title":"Dig Dis Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/intimm\/dxz076","article-title":"Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production","volume":"32","author":"Tachibana","year":"2020","journal-title":"Int Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","first-page":"eabc5367","DOI":"10.1126\/sciimmunol.abc5367","article-title":"HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19","volume":"5","author":"Spinelli","year":"2020","journal-title":"Sci Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00535-017-1401-7","article-title":"Clinical importance of IL-22 cascade in IBD","volume":"53","author":"Mizoguchi","year":"2018","journal-title":"J Gastroenterol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2295.","article-title":"Interleukin-22 and intestinal homeostasis: protective or destructive?","author":"Shohan","year":"2020","journal-title":"IUBMB Life"},{"key":"B82","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1128\/AAC.47.1.196-203.2003","article-title":"Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus","volume":"47","author":"Fey","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e1002271","DOI":"10.1371\/journal.ppat.1002271","article-title":"A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia","volume":"7","author":"Wilson","year":"2011","journal-title":"PLoS Pathog"},{"key":"B84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ng.3147","article-title":"Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance","volume":"47","author":"Davies","year":"2015","journal-title":"Nat Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1080\/21505594.2017.1325070","article-title":"Enhanced nasopharyngeal infection and shedding associated with an epidemic lineage of emm3 group A Streptococcus","volume":"8","author":"Afshar","year":"2017","journal-title":"Virulence"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0180757","DOI":"10.1371\/journal.pone.0180757","article-title":"Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014","volume":"12","author":"Imohl","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T19:22:29Z","timestamp":1593199349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2020.01311"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01311","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"article-number":"1311"}}